|
1
|
Kivelä T: The epidemiological challenge of
the most frequent eye cancer: Retinoblastoma, an issue of birth and
death. Br J Ophthalmol. 93:1129–1131. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Broaddus E, Topham A and Singh AD:
Incidence of retinoblastoma in the USA: 1975–2004. Br J Ophthalmol.
93:21–23. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Shields CL and Shields JA: Retinoblastoma
management: Advances in enucleation, intravenous chemoreduction,
and intra-arterial chemotherapy. Curr Opin Ophthalmol. 21:203–212.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Benavente CA and Dyer MA: Genetics and
epigenetics of human retinoblastoma. Annu Rev Pathol. 10:547–562.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Gupta R, Vemuganti GK, Reddy VA and
Honavar SG: Histopathologic risk factors in retinoblastoma in
India. Arch Pathol Lab Med. 133:1210–1214. 2009.PubMed/NCBI
|
|
6
|
Khelfaoui F, Validire P, Auperin A,
Quintana E, Michon J, Pacquement H, Desjardins L, Asselain B,
Schlienger P, Vielh P, et al: Histopathologic risk factors in
retinoblastoma: A retrospective study of 172 patients treated in a
single institution. Cancer. 77:1206–1213. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Dimaras H, Kimani K, Dimba EA, Gronsdahl
P, White A, Chan HS and Gallie BL: Retinoblastoma. Lancet.
379:1436–1446. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kaliki S, Shields CL, Rojanaporn D,
Al-Dahmash S, McLaughlin JP, Shields JA and Eagle RC Jr: High-risk
retinoblastoma based on international classification of
retinoblastoma: Analysis of 519 enucleated eyes. Ophthalmology.
120:997–1003. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Canturk S, Qaddoumi I, Khetan V, Ma Z,
Furmanchuk A, Antoneli CB, Sultan I, Kebudi R, Sharma T,
Rodriguez-Galindo C, et al: Survival of retinoblastoma in
less-developed countries impact of socioeconomic and health-related
indicators. Br J Ophthalmol. 94:1432–1436. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Oliveto S, Mancino M, Manfrini N and Biffo
S: Role of microRNAs in translation regulation and cancer. World J
Biol Chem. 8:45–56. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Liu J: Control of protein synthesis and
mRNA degradation by microRNAs. Curr Opin Cell Biol. 20:214–221.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Calin GA and Croce CM: MicroRNA signatures
in human cancers. Nat Rev Cancer. 6:857–866. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Liu Y, Zhou Y, Gong X and Zhang C:
MicroRNA-30a-5p inhibits the proliferation and invasion of gastric
cancer cells by targeting insulin-like growth factor 1 receptor.
Exp Ther Med. 14:173–180. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Song D, Diao J, Yang Y and Chen Y:
MicroRNA382 inhibits cell proliferation and invasion of
retinoblastoma by targeting BDNF-mediated PI3K/AKT signalling
pathway. Mol Med Rep. 16:6428–6436. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhou Y, Li R, Yu H, Wang R and Shen Z:
microRNA-130a is an oncomir suppressing the expression of CRMP4 in
gastric cancer. Onco Targets Ther. 10:3893–3905. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yu H, Duan P, Zhu H and Rao D: miR-613
inhibits bladder cancer proliferation and migration through
targeting SphK1. Am J Transl Res. 9:1213–1221. 2017.PubMed/NCBI
|
|
18
|
Qu W, Chen X, Wang J, Lv J and Yan D:
MicroRNA-1 inhibits ovarian cancer cell proliferation and migration
through c-Met pathway. Clin Chim Acta. 473:237–244. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wu D, Niu X, Pan H, Zhou Y, Zhang Z, Qu P
and Zhou J: Tumor-suppressing effects of microRNA-429 in human
renal cell carcinoma via the downregulation of Sp1. Oncol Lett.
12:2906–2911. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhang P, Kong F, Deng X, Yu Y, Hou C,
Liang T and Zhu L: MicroRNA-326 suppresses the proliferation,
migration and invasion of cervical cancer cells by targeting ELK1.
Oncol Lett. 13:2949–2956. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wang H, Zhan Y, Jin J, Zhang C and Li W:
MicroRNA-15b promotes proliferation and invasion of nonsmall cell
lung carcinoma cells by directly targeting TIMP2. Oncol Rep.
37:3305–3312. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Yu DL, Zhang T, Wu K, Li Y, Wang J, Chen
J, Li XQ, Peng XG, Wang JN and Tan LG: MicroRNA-448 suppresses
metastasis of pancreatic ductal adenocarcinoma through targeting
JAK1/STAT3 pathway. Oncol Rep. 38:1075–1082. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Shan C, Fei F, Li F, Zhuang B, Zheng Y,
Wan Y and Chen J: miR-448 is a novel prognostic factor of lung
squamous cell carcinoma and regulates cells growth and metastasis
by targeting DCLK1. Biomed Pharmacother. 89:1227–1234. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Li B, Ge L, Li M, Wang L and Li Z: miR-448
suppresses proliferation and invasion by regulating IGF1R in
colorectal cancer cells. Am J Transl Res. 8:3013–3022.
2016.PubMed/NCBI
|
|
25
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zang QQ, Zhang L, Gao N and Huang C:
Ophiopogonin D inhibits cell proliferation, causes cell cycle
arrest at G2/M, and induces apoptosis in human breast carcinoma
MCF-7 cells. J Integr Med. 14:51–59. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Han BH, Lee YJ, Yoon JJ, Choi ES, Namgung
S, Jin XJ, Jeong DH, Kang DG and Lee HS: Hwangryunhaedoktang exerts
anti-inflammation on LPS-induced NO production by suppressing MAPK
and NF-kappaB activation in RAW264.7 macrophages. J Integr Med.
15:326–336. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zhan Y, Zheng N, Teng F, Bao L, Liu F,
Zhang M, Guo M, Guo W, Ding G and Wang Q: miR-199a/b-5p inhibits
hepatocellular carcinoma progression by post-transcriptionally
suppressing ROCK1. Oncotarget. 8:67169–67180. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Jiang R, Zhang C, Liu G, Gu R and Wu H:
MicroRNA-101 inhibits proliferation, migration and invasion in
osteosarcoma cells by targeting ROCK1. Am J Cancer Res. 7:88–97.
2017.PubMed/NCBI
|
|
30
|
Gu X, Meng S, Liu S, Jia C, Fang Y, Li S,
Fu C, Song Q, Lin L and Wang X: miR-124 represses ROCK1 expression
to promote neurite elongation through activation of the PI3K/Akt
signal pathway. J Mol Neurosci. 52:156–165. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Yang Y and Mei Q: miRNA signature
identification of retinoblastoma and the correlations between
differentially expressed miRNAs during retinoblastoma progression.
Mol Vis. 21:1307–1317. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Beta M, Venkatesan N, Vasudevan M,
Vetrivel U, Khetan V and Krishnakumar S: Identification and
insilico analysis of retinoblastoma serum microRNA profile and gene
targets towards prediction of novel serum biomarkers. Bioinform
Biol Insights. 7:21–34. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Liu S, Hu C, Wang Y, Shi G, Li Y and Wu H:
miR-124 inhibits proliferation and invasion of human retinoblastoma
cells by targeting STAT3. Oncol Rep. 36:2398–2404. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Zhu H, Zhou X, Ma C, Chang H, Li H, Liu F
and Lu J: Low expression of miR-448 induces EMT and promotes
invasion by regulating ROCK2 in hepatocellular carcinoma. Cell
Physiol Biochem. 36:487–498. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Wu X, Tang H, Liu G, Wang H, Shu J and Sun
F: miR-448 suppressed gastric cancer proliferation and invasion by
regulating ADAM10. Tumour Biol. 37:10545–10551. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Lv Y, Lei Y, Hu Y, Ding W, Zhang C and
Fang C: miR-448 negatively regulates ovarian cancer cell growth and
metastasis by targeting CXCL12. Clin Transl Oncol. 17:903–909.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Wu X, Yan L, Liu Y, Xian W, Wang L and
Ding X: MicroRNA-448 suppresses osteosarcoma cell proliferation and
invasion through targeting EPHA7. PLoS One. 12:e01755532017.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Jiang W, Wang S, Sun Y, Jiang Y, Yu T and
Wang J: Overexpression of microRNA-448 inhibits osteosarcoma cell
proliferation and invasion through targeting of astrocyte elevated
gene-1. Mol Med Rep. 16:5713–5721. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Shen L, Liu L, Ge L, Xie L, Liu S, Sang L,
Zhan T and Li H: miR-448 downregulates MPPED2 to promote cancer
proliferation and inhibit apoptosis in oral squamous cell
carcinoma. Exp Ther Med. 12:2747–2752. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Whatcott CJ, Ng S, Barrett MT, Hostetter
G, Von Hoff DD and Han H: Inhibition of ROCK1 kinase modulates both
tumor cells and stromal fibroblasts in pancreatic cancer. PLoS One.
12:e01838712017. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Wu YJ, Tang Y, Li ZF, Li Z, Zhao Y, Wu ZJ
and Su Q: Expression and significance of Rac1, Pak1 and Rock1 in
gastric carcinoma. Asia Pac J Clin Oncol. 10:e33–e39. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Cui G, Cui M, Li Y, Liang Y, Li W, Guo H
and Zhao S: miR-186 targets ROCK1 to suppress the growth and
metastasis of NSCLC cells. Tumour Biol. 35:8933–8937. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Zhang J, He X, Ma Y, Liu Y, Shi H, Guo W
and Liu L: Overexpression of ROCK1 and ROCK2 inhibits human
laryngeal squamous cell carcinoma. Int J Clin Exp Pathol.
8:244–251. 2015.PubMed/NCBI
|
|
44
|
Bu Q, Tang HM, Tan J, Hu X and Wang DW:
Expression of RhoC and ROCK-1 and their effects on MAPK and Akt
proteins in prostate carcinoma. Zhonghua Zhong Liu Za Zhi.
33:202–206. 2011.(In Chinese). PubMed/NCBI
|
|
45
|
Xiang J, Wu Y, Li DS, Wang ZY, Shen Q, Sun
TQ, Guan Q and Wang YJ: miR-584 suppresses invasion and cell
migration of thyroid carcinoma by regulating the target oncogene
ROCK1. Oncol Res Treat. 38:436–440. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Zhang P, Lu Y, Liu XY and Zhou YH:
Knockdown of Rho-associated protein kinase 1 suppresses
proliferation and invasion of glioma cells. Tumour Biol.
36:421–428. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Abe H, Kamai T, Hayashi K, Anzai N,
Shirataki H, Mizuno T, Yamaguchi Y, Masuda A, Yuki H, Betsunoh H,
et al: The Rho-kinase inhibitor HA-1077 suppresses
proliferation/migration and induces apoptosis of urothelial cancer
cells. BMC Cancer. 14:4122014. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Leonel C, Ferreira LC, Borin TF, Moschetta
MG, Freitas GS, Haddad MR, de Camargos Pinto Robles JA and de
Campos Aparecida Pires Zuccari D: Inhibition of
Epithelial-mesenchymal transition in response to treatment with
metformin and Y27632 in breast cancer cell lines. Anticancer Agents
Med Chem. 17:1113–1125. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Wang J, Liu XH, Yang ZJ, Xie B and Zhong
YS: The effect of ROCK-1 activity change on the adhesive and
invasive ability of Y79 retinoblastoma cells. BMC Cancer.
14:892014. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Zheng B, Liang L, Wang C, Huang S, Cao X,
Zha R, Liu L, Jia D, Tian Q, Wu J, et al: MicroRNA-148a suppresses
tumor cell invasion and metastasis by downregulating ROCK1 in
gastric cancer. Clin Cancer Res. 17:7574–7583. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Liu Y, Liu J, Wang L, Yang X and Liu X:
MicroRNA195 inhibits cell proliferation, migration and invasion in
laryngeal squamous cell carcinoma by targeting ROCK1. Mol Med Rep.
16:7154–7162. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Julian L and Olson MF: Rho-associated
coiled-coil containing kinases (ROCK): Structure, regulation, and
functions. Small GTPases. 5:e298462014. View Article : Google Scholar : PubMed/NCBI
|
